Literature DB >> 9482240

Cytokines, signal transduction, and inflammatory demyelination: review and hypothesis.

R W Ledeen1, G Chakraborty.   

Abstract

The mechanism of focal demyelination in multiple sclerosis has been a long-standing enigma of this disorder. Cytokines, a diverse family of signalling molecules, are viewed as potential mediators of the process based on clinical observations and studies with animal models and tissue/cell culture systems. Myelin and oligodendrocyte (OL) destruction occur in cultured preparations subjected to cytokines such as tumor necrosis factor-alpha (TNF alpha) and lymphotoxin (LT). Many studies have shown these and other cytokines to be elevated at lesion sites and in the CSF of multiple sclerosis (MS) patients, with similar findings in animal models. Some variability in the nature of MS lesion formation has been reported, both OLs and myelin being primary targets. To account for myelin destruction in the presence of apparently functional OLs we hypothesize that cytokines such as TNF alpha and LT alpha contribute to myelin damage through triggering of specific reactions within the myelin sheath. We further propose that neutral sphingomyelinase (SMase) is one such enzyme, two forms of which have been detected in purified myelin. An additional event is accumulation of cholesterol ester, apparently a downstream consequence of cytokine-induced SMase. The resulting lipid changes are viewed as potentially destabilizing to myelin, which may render it more vulnerable to attack by invading and resident phagocytes.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9482240     DOI: 10.1023/a:1022493013904

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  166 in total

1.  Cytokine accumulations in CSF of multiple sclerosis patients: frequent detection of interleukin-1 and tumor necrosis factor but not interleukin-6.

Authors:  S L Hauser; T H Doolittle; R Lincoln; R H Brown; C A Dinarello
Journal:  Neurology       Date:  1990-11       Impact factor: 9.910

2.  Purification of phosphatidylinositol kinase from bovine brain myelin.

Authors:  A R Saltiel; J A Fox; P Sherline; N Sahyoun; P Cuatrecasas
Journal:  Biochem J       Date:  1987-02-01       Impact factor: 3.857

3.  Identification of GTP-binding proteins in myelin and oligodendrocyte membranes.

Authors:  P E Braun; E Horvath; V W Yong; L Bernier
Journal:  J Neurosci Res       Date:  1990-05       Impact factor: 4.164

4.  Phosphorylation of endogenous protein of rat brain by cyclic adenosine 3',5'-monophosphate-dependent protein kinase.

Authors:  E M Johnson; H Maeno; P Greengard
Journal:  J Biol Chem       Date:  1971-12-25       Impact factor: 5.157

5.  Regulation of macrophage function by interferon-gamma. Somatic cell genetic approaches in murine macrophage cell lines to mechanisms of growth inhibition, the oxidative burst, and expression of the chronic granulomatous disease gene.

Authors:  M Goldberg; L S Belkowski; B R Bloom
Journal:  J Clin Invest       Date:  1990-02       Impact factor: 14.808

6.  Characterization and distribution of phagocytic macrophages in multiple sclerosis plaques.

Authors:  H Li; J Newcombe; N P Groome; M L Cuzner
Journal:  Neuropathol Appl Neurobiol       Date:  1993-06       Impact factor: 8.090

7.  Phosphate groups modifying myelin basic proteins are metabolically labile; methyl groups are stable.

Authors:  K C DesJardins; P Morell
Journal:  J Cell Biol       Date:  1983-08       Impact factor: 10.539

8.  Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion.

Authors:  C S Raine; L Scheinberg; J M Waltz
Journal:  Lab Invest       Date:  1981-12       Impact factor: 5.662

9.  Tumor necrosis factor-alpha messenger RNA expression in patients with relapsing-remitting multiple sclerosis is associated with disease activity.

Authors:  P Rieckmann; M Albrecht; B Kitze; T Weber; H Tumani; A Broocks; W Lüer; A Helwig; S Poser
Journal:  Ann Neurol       Date:  1995-01       Impact factor: 10.422

10.  Vascular cell adhesion molecule-1 modulation by tumor necrosis factor in experimental allergic encephalomyelitis.

Authors:  D M Barten; N H Ruddle
Journal:  J Neuroimmunol       Date:  1994-05       Impact factor: 3.478

View more
  8 in total

1.  Acute multiple sclerosis characterized by extensive mononuclear phagocyte infiltration.

Authors:  D C Shields; N G Avgeropoulos; N L Banik; W R Tyor
Journal:  Neurochem Res       Date:  2000-11       Impact factor: 3.996

2.  Targeted expression of baculovirus p35 caspase inhibitor in oligodendrocytes protects mice against autoimmune-mediated demyelination.

Authors:  S Hisahara; T Araki; F Sugiyama; K i Yagami; M Suzuki; K Abe; K Yamamura; J Miyazaki; T Momoi; T Saruta; C C Bernard; H Okano; M Miura
Journal:  EMBO J       Date:  2000-02-01       Impact factor: 11.598

3.  NR4A1 agonist cytosporone B attenuates neuroinflammation in a mouse model of multiple sclerosis.

Authors:  Hai-Zhen Yu; Bing-Qing Zhu; Lin Zhu; Shuo Li; Li-Mei Wang
Journal:  Neural Regen Res       Date:  2022-12       Impact factor: 6.058

Review 4.  Ceramide and neurodegeneration: susceptibility of neurons and oligodendrocytes to cell damage and death.

Authors:  Arundhati Jana; Edward L Hogan; Kalipada Pahan
Journal:  J Neurol Sci       Date:  2009-01-14       Impact factor: 3.181

Review 5.  B cells and autoantibodies in the pathogenesis of multiple sclerosis and related inflammatory demyelinating diseases.

Authors:  Katherine A McLaughlin; Kai W Wucherpfennig
Journal:  Adv Immunol       Date:  2008       Impact factor: 3.543

Review 6.  Connexins and their channels in inflammation.

Authors:  Joost Willebrords; Sara Crespo Yanguas; Michaël Maes; Elke Decrock; Nan Wang; Luc Leybaert; Brenda R Kwak; Colin R Green; Bruno Cogliati; Mathieu Vinken
Journal:  Crit Rev Biochem Mol Biol       Date:  2016-07-07       Impact factor: 8.250

7.  CCR5 knockout suppresses experimental autoimmune encephalomyelitis in C57BL/6 mice.

Authors:  Sun Mi Gu; Mi Hee Park; Hyung Mun Yun; Sang Bae Han; Ki Wan Oh; Dong Ju Son; Jae Suk Yun; Jin Tae Hong
Journal:  Oncotarget       Date:  2016-03-29

8.  The TNF-alpha system: functional aspects in depression, narcolepsy and psychopharmacology.

Authors:  Mark Berthold-Losleben; Hubertus Himmerich
Journal:  Curr Neuropharmacol       Date:  2008-09       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.